Crinetics Pharmaceuticals Inc buy JPMorgan Chase & Co.
Start price
20.11.23
/
50%
€27.40
Target price
20.11.24
€32.04
Performance (%)
100.73%
End price
21.11.24
€55.00
Summary
This prediction ended on 21.11.24 with a price of €55.00. The BUY prediction by JPMorgan_Chase___Co_ for Crinetics Pharmaceuticals Inc saw massive gains of 100.73%. JPMorgan_Chase___Co_ has a follow-up prediction for Crinetics Pharmaceuticals Inc where he still thinks Crinetics Pharmaceuticals Inc is a Buy. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Crinetics Pharmaceuticals Inc | 3.145% | 3.145% | 3.145% |
| iShares Core DAX® | -2.117% | -7.974% | -1.733% |
| iShares Nasdaq 100 | -1.323% | -0.066% | 16.602% |
| iShares Nikkei 225® | -0.324% | -6.382% | 25.629% |
| iShares S&P 500 | -1.568% | -1.965% | 10.831% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Crinetics Pharmaceuticals Inc diskutieren
Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) had its "overweight" rating re-affirmed by analysts at JPMorgan Chase & Co.. They now have a $35.00 price target on the stock.
Ratings data for CRNX provided by MarketBeat
In the thread Trading Crinetics Pharmaceuticals Inc
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten
Current prediction by JPMorgan_Chase___Co_ for Crinetics Pharmaceuticals Inc
Crinetics Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€30.40
24.09.25
24.09.25
€44.06
24.09.26
24.09.26
7.89%
17.03.26
17.03.26
Stopped prediction by JPMorgan_Chase___Co_ for Crinetics Pharmaceuticals Inc
Crinetics Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€44.60
09.07.24
09.07.24
€49.94
09.07.25
09.07.25
-39.01%
10.07.25
10.07.25